Paper · 1104746
Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.
Debré P and 2 others. J Exp Med, 1975. Cited by 91 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. Papers, record 1104746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1104746
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Antigens | Major topic |
| Immune Tolerance | Major topic |
| Mice, Inbred BALB C | Major topic |
| Animals | |
| Glutamates | |
| Hemolytic Plaque Technique | |
| Immunization | |
| Immunoglobulin G | |
| Immunosuppressive Agents | |
| Kinetics | |
| Mice | |
| Polymers | |
| Serum Albumin, Bovine | |
| Species Specificity | |
| Spleen | |
| Tyrosine |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 13,918,158 | Fractionation of nucleic acids with the methylated albumin column. | J Mol Biol | 1962 | https://conductscience.org/library/papers/13918158 | PubMed |
| 2 | 4,126,766 | Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro. | J Exp Med | 1973 | https://conductscience.org/library/papers/4126766 | PubMed |
| 3 | 4,137,682 | Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). | J Exp Med | 1974 | https://conductscience.org/library/papers/4137682 | PubMed |
| 4 | 4,109,878 | Histocompatibility-linked immune response genes. | Science | 1972 | https://conductscience.org/library/papers/4109878 | PubMed |
| 5 | 4,539,650 | A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4539650 | PubMed |
| 6 | 4,857,865 | Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice. | J Exp Med | 1974 | https://conductscience.org/library/papers/4857865 | PubMed |
| 7 | 4,750,862 | Mapping the H-2-linked genes governing, respectively, the immune responses to a glutamic acid-alanine-tyrosine copolymer and to limiting doses of ovalbumin. | J Immunol | 1973 | https://conductscience.org/library/papers/4750862 | PubMed |
| 8 | 4,908,392 | Genetic control of specific immune responses. | Adv Immunol | 1969 | https://conductscience.org/library/papers/4908392 | PubMed |
| 9 | 4,934,502 | Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes. | J Exp Med | 1971 | https://conductscience.org/library/papers/4934502 | PubMed |
| 10 | 5,559,610 | Specific immune response genes of the guinea pig. I. Dominant genetic control of immune responsiveness to copolymers of L-glutamic acid and L-alanine and L-glutamic acid and L-tyrosine. | J Exp Med | 1971 | https://conductscience.org/library/papers/5559610 | PubMed |
1 to 10 of 11
See all 11 referencesCited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 18,154,615 | Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. | Immunology | 2008 | https://conductscience.org/library/papers/18154615 | PubMed |
| 9,730,897 | Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b). | J Exp Med | 1998 | https://conductscience.org/library/papers/9730897 | PubMed |
| 8,747,923 | The SMXA: a new set of recombinant inbred strain of mice consisting of 26 substrains and their genetic profile. | Mamm Genome | 1995 | https://conductscience.org/library/papers/8747923 | PubMed |
| 7,106,845 | Differential sensitivity of lymphocyte subsets to corticosteroid treatment. | Immunology | 1982 | https://conductscience.org/library/papers/7106845 | PubMed |
| 7,047,670 | Gain/loss of poly(Glu50Tyr50)/poly(Glu60Ala30Tyr10) responsiveness in the bm12 mutant strain. | J Exp Med | 1982 | https://conductscience.org/library/papers/7047670 | PubMed |
| 7,011,980 | Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice. | Infect Immun | 1980 | https://conductscience.org/library/papers/7011980 | PubMed |
| 6,801,188 | Regulation of immune responses by I-J gene products. II. Presence of Both I-Jb and I-Jk suppressor factors in (nonsuppressor x nonsuppressor) F1 mice. | J Exp Med | 1982 | https://conductscience.org/library/papers/6801188 | PubMed |
| 6,800,943 | Genetic analysis of immune suppression. I. Gene complementation is required for suppression of antigen-specific proliferative responses by T-cell derived factors. | Immunogenetics | 1981 | https://conductscience.org/library/papers/6800943 | PubMed |
| 6,792,727 | Helper and suppressor T cell factors. | Springer Semin Immunopathol | 1980 | https://conductscience.org/library/papers/6792727 | PubMed |
| 6,602,202 | Hapten-reactive inducer T cells. I. Definition of two classes of hapten-specific inducer cells. | J Exp Med | 1983 | https://conductscience.org/library/papers/6602202 | PubMed |
1 to 10 of 33
See all 33 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1104746
GET https://conductscience.org/api/papers/v1/1104746/cited_by?page=2